Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Inclusion Criteria: * Type 2 diabetes treated with biphasic human insulin with or without metformin * Inadequate glycaemic control or is experiencing hypoglycaemic events or would, in the physician's opinion, benefit from treatment with NovoMix® 50 Exclusion Criteria: * Subjects with diagnosed type 1 diabetes mellitus * Subjects treated with short acting or intermediate acting human insulin or any insulin analogue * Subjects who are unlikely to comply with study description, e.g. uncooperative attitude, inability to come for regular visits * Subjects with a hypersensitivity to biphasic insulin aspart 50 (NovoMix® 50 )or to any of the excipients * Women of childbearing potential, who are pregnant, breast-feeding or intend to become pregnant within next 12 months